Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tonic 4-1BB Costimulation in Chimeric Antigen Receptors Impedes T Cell Survival and Is Vector-Dependent
Diogo Gomes‐Silva, Malini Mukherjee, Madhuwanti Srinivasan, et al.
Cell Reports (2017) Vol. 21, Iss. 1, pp. 17-26
Open Access | Times Cited: 237

Showing 1-25 of 237 citing articles:

Clinical lessons learned from the first leg of the CAR T cell journey
Robbie G. Majzner, Crystal L. Mackall
Nature Medicine (2019) Vol. 25, Iss. 9, pp. 1341-1355
Closed Access | Times Cited: 517
Enhancing CAR T cell persistence through ICOS and 4-1BB costimulation
Sònia Guedan, Avery D. Posey, Carolyn E. Shaw, et al.
JCI Insight (2018) Vol. 3, Iss. 1
Open Access | Times Cited: 481
Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells
Mohamed-Reda Benmebarek, Clara H. Karches, Bruno L. Cadilha, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 6, pp. 1283-1283
Open Access | Times Cited: 416
Engineering and Design of Chimeric Antigen Receptors
Sònia Guedan, Hugo Calderón, Avery D. Posey, et al.
Molecular Therapy — Methods & Clinical Development (2018) Vol. 12, pp. 145-156
Open Access | Times Cited: 347
Emerging Cellular Therapies for Cancer
Sònia Guedan, Marco Ruella, Carl H. June
Annual Review of Immunology (2018) Vol. 37, Iss. 1, pp. 145-171
Open Access | Times Cited: 322
GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells
Eric L. Smith, Kim Harrington, Mette Stæhr, et al.
Science Translational Medicine (2019) Vol. 11, Iss. 485
Open Access | Times Cited: 317
Recent advances in CAR-T cell engineering
Ruihao Huang, Xiaoping Li, Yundi He, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 296
CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?
Jessica Wagner, Elizabeth Wickman, Christopher DeRenzo, et al.
Molecular Therapy (2020) Vol. 28, Iss. 11, pp. 2320-2339
Open Access | Times Cited: 293
Selecting costimulatory domains for chimeric antigen receptors: functional and clinical considerations
Robert Weinkove, P J George, Nathaniel Dasyam, et al.
Clinical & Translational Immunology (2019) Vol. 8, Iss. 5
Open Access | Times Cited: 259
In Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin’s Lymphomas
Carlos A. Ramos, Rayne H. Rouce, Catherine Robertson, et al.
Molecular Therapy (2018) Vol. 26, Iss. 12, pp. 2727-2737
Open Access | Times Cited: 245
CAR-T design: Elements and their synergistic function
Jayapriya Jayaraman, Michael Mellody, Andrew J. Hou, et al.
EBioMedicine (2020) Vol. 58, pp. 102931-102931
Open Access | Times Cited: 244
A comparison of chimeric antigen receptors containing CD28 versus 4-1BB costimulatory domains
Kathryn M. Cappell, James N. Kochenderfer
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 11, pp. 715-727
Closed Access | Times Cited: 241
T cell senescence and CAR-T cell exhaustion in hematological malignancies
Dimitri Kasakovski, Ling Xu, Yangqiu Li
Journal of Hematology & Oncology (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 229
Expanding the Therapeutic Window for CAR T Cell Therapy in Solid Tumors: The Knowns and Unknowns of CAR T Cell Biology
Keisuke Watanabe, Shunichiro Kuramitsu, Avery D. Posey, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 220
CAR T cells for infection, autoimmunity and allotransplantation
Colby R. Maldini, Gavin I. Ellis, James L. Riley
Nature reviews. Immunology (2018) Vol. 18, Iss. 10, pp. 605-616
Open Access | Times Cited: 203
Strategies to Address Chimeric Antigen Receptor Tonic Signaling
Adam Ajina, John Maher
Molecular Cancer Therapeutics (2018) Vol. 17, Iss. 9, pp. 1795-1815
Open Access | Times Cited: 188
SynNotch CAR circuits enhance solid tumor recognition and promote persistent antitumor activity in mouse models
Axel Hyrenius‐Wittsten, Su Yang, Minhee Park, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 591
Open Access | Times Cited: 167
CAR T-Cell Associated Neurotoxicity: Mechanisms, Clinicopathologic Correlates, and Future Directions
Bradley D. Hunter, Caron A. Jacobson
JNCI Journal of the National Cancer Institute (2019) Vol. 111, Iss. 7, pp. 646-654
Open Access | Times Cited: 156
Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy
Stefan Stoiber, Bruno L. Cadilha, Mohamed-Reda Benmebarek, et al.
Cells (2019) Vol. 8, Iss. 5, pp. 472-472
Open Access | Times Cited: 153
CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity
Tim Sauer, Kathan Parikh, Sandhya Sharma, et al.
Blood (2021) Vol. 138, Iss. 4, pp. 318-330
Open Access | Times Cited: 152
Chimeric STAR receptors using TCR machinery mediate robust responses against solid tumors
Yue Liu, Guangna Liu, Jiasheng Wang, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 586
Closed Access | Times Cited: 109
Cancer immunotherapy: Challenges and limitations
Sina Taefehshokr, Aram Parhizkar, Shima Hayati, et al.
Pathology - Research and Practice (2021) Vol. 229, pp. 153723-153723
Closed Access | Times Cited: 108
Allogeneic CD20‐targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B‐cell lymphoma models
Kevin Nishimoto, Taylor Barca, Aruna Azameera, et al.
Clinical & Translational Immunology (2022) Vol. 11, Iss. 2
Open Access | Times Cited: 79
Co-Stimulatory Receptor Signaling in CAR-T Cells
Mackenzie M. Honikel, Scott H. Olejniczak
Biomolecules (2022) Vol. 12, Iss. 9, pp. 1303-1303
Open Access | Times Cited: 72
Lipid nanoparticles outperform electroporation in mRNA-based CAR T cell engineering
Reni Kitte, Martin Rabel, Reka Geczy, et al.
Molecular Therapy — Methods & Clinical Development (2023) Vol. 31, pp. 101139-101139
Open Access | Times Cited: 43
Page 1 - Next Page

Scroll to top